Sheryl Martin-Moe

Sherry is a Biopharmaceutical executive leader with over 30 years of experience in the pharmaceutical, biotechnology, diagnostic and device industries in the US, Europe, and ROW. She is a Concept to Product CMC expert with demonstrated success in bringing over 100 products through development, clinical trials, and to market and supporting licensed products. She has a breadth of cross-functional leadership experience, directing departments including Analytical, Formulation, Device, and Processing Development; Clinical and Commercial Quality Control; and Clinical Production for Drug Substance and Drug products. Sherry has established a scientific track record for designing and successfully implementing integrated programs including CMC, Development, Operations, Combination Products, Technology Transfers, Drug Product Network Process, Comparability, QbD, and Process Validation.